huB-F5

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamehuB-F5
Drug Alias Nameanti-CD4 humanized monoclonal antibody (Diaclone)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationFrance
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesDiaclone SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiaclone SA
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A